Ondanstron Weekly vs Every 3 Weeks for Prevention of Nausea and Vomiting Induced by Chemotherapy Combined With PD-1 Blockade
Clinical trial NCT06080880 · RECRUITING
Trial details
- NCT number
- NCT06080880
- Sponsor
- Hubei Cancer Hospital
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2025-11-01
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.